The aim of this retrospective study was to evaluate the cumulative survival rate of implants placed in partially or total edentulous patients.
Methods:
A total of 1649 implants were placed in 238 patients. The observation period and follow up after implantation was 7 year. The implant groups included Xive , 3i , Noble , F2 , Biocare , Biohorizone. The patients were partially or total edentulous. The study is a historical cohort and all case information which used were documented.
Results:
The cumulative survival rate of these all implants was 98.1%. The most survival rate was for Xive trademark and F2 had the lowest survival rate .
Conclusions:
osseointegrated implants have become a predictable treatment alternative in partially or fully edentulous patients and for single tooth replacements